Turnaround depends on China and cost cuts
- Q3 FY26 sales rose 5%, but only 2% after removing currency moves.
- The Americas grew 1% for a second straight positive quarter, which points to stabilization, not yet a strong rebound.
- Asia/Pacific was flat, and management still cites a duty-free retailer change at Beijing and Shanghai airports.
- Mainland China grew 11%, making it the clearest bright spot in the current recovery.
- The PRGP savings target rose to $1.0-$1.2 billion, but investors still need to see those savings reach profit.
A recovery with weak spots
Estée Lauder is trying to climb out of a hard period for prestige beauty. Q3 FY26 kept the recovery alive: total sales grew 5% from last year, or 2% in constant currency, which removes exchange-rate moves. That was slower than Q2 FY26, when sales grew 6%.
The bull case is cleaner than it was a year ago. The Americas grew 1% for a second straight positive quarter, so the largest drag is no longer getting worse. Mainland China grew 11%, and fragrance brands like Le Labo, TOM FORD, and Kilian Paris are still pulling demand.
The bear case is that the rebound is losing speed. Asia/Pacific was flat, and the Asia travel retail issue tied to duty-free retailer changes at Beijing and Shanghai airports is lasting longer than hoped. The cost plan helps, since management lifted its PRGP gross savings target to $1.0-$1.2 billion, but this is still a show-me story. Sales need to improve, and savings need to flow through to profit.
Luxury brands, many selling channels
Estée Lauder makes money by selling prestige beauty products under brands such as Estée Lauder, Clinique, La Mer, M·A·C, Jo Malone London, TOM FORD, Too Faced, Dr.Jart+, and The Ordinary. It sells through its own websites and stores, department stores, specialty retailers, airports, duty-free shops, and other authorized channels.
The company protects its luxury image with selective distribution and a High-Touch service model, meaning beauty advice, samples, and personal service are part of the sale. That can support pricing when the brands are healthy. It can also hurt when key retailers slow orders or carry too much inventory.
The model is tied to global travel, China demand, and retailer relationships. That makes the business more fragile than a basic consumer staples company. The Lauder family also controls about 84% of the voting power, so outside shareholders have limited say over big governance choices.
Skin care pays, fragrance grows
Skin Care
Skin Care was $1.86 billion in Q3 FY26, or 50.0% of net sales, and grew 3%. Key brands include Estée Lauder, La Mer, Clinique, Dr.Jart+, and The Ordinary.
Makeup
Makeup was $1.07 billion in Q3 FY26, or 28.9% of net sales, and grew 4%. The next-generation Double Wear foundation helped the Estée Lauder brand.
Fragrance
Fragrance was $0.63 billion in Q3 FY26, or 16.9% of net sales, and grew 13%. Le Labo, TOM FORD, and Kilian Paris led the category.
Hair Care
Hair Care was $0.13 billion in Q3 FY26, or 3.5% of net sales, and grew 2%. Aveda and Bumble and bumble are the main brands.
Q3 FY26 product mix
The mix below uses net sales by product category for Q3 FY26 ended March 31, 2026. Skin Care is half of sales, so any weakness there can move the whole company.
What could break the rebound
Asia travel retail stays weak
High impact · Medium oddsAsia/Pacific was flat in Q3 FY26, and management still points to a transitory headwind from duty-free retailer changes at Beijing and Shanghai airports. If this does not clear, a key high-end selling channel may stay below normal.
The Americas stalls again
Medium impact · Medium oddsThe Americas has improved, but Q3 FY26 growth was only 1%. That is better than declines, yet it leaves little room for another hit from weak department stores, store closures, or destocking.
Cost savings fail to reach profit
High impact · Medium oddsThe PRGP savings target rose to $1.0-$1.2 billion, which is central to the bull case. The risk is that savings get offset by restructuring charges, tariffs, inflation, or reinvestment, so margins recover less than investors expect.
Brand values fall again
High impact · Medium oddsIn fiscal 2025, Estée Lauder recorded $1.286 billion of impairment charges tied to TOM FORD, Dr.Jart+, and Too Faced. Impairments are non-cash, but they signal that past brand growth hopes were too high.
Talc litigation costs grow
Medium impact · Medium oddsThe company recorded a $159 million charge in Q1 FY25 for settlement agreements related to cosmetic talcum powder products. More claims or higher settlement costs could pressure earnings and distract management.
Family control limits outside influence
Medium impact · High oddsThe Lauder family controls about 84% of the voting power. This can support long-term thinking, but it also means public shareholders have little power if they disagree with strategy, leadership, or board choices.
In one breath
Why has Estée Lauder struggled?
The biggest problems have been weaker demand in China, a sharp drop in Asia travel retail, and retailer destocking in North America. Skin Care has been hit hardest because it is the largest product category.
What is the PRGP?
PRGP stands for Profit Recovery and Growth Plan. It is management's cost-saving and restructuring plan, now targeting $1.0-$1.2 billion of annual gross savings.
Is China still important for Estée Lauder?
Yes. Mainland China grew 11% in Q3 FY26 and is one of the brightest areas right now. But China and travel retail have also been major sources of volatility, so the company needs steady demand there.
What should investors watch next?
Watch for Asia/Pacific growth to re-accelerate, The Americas to move beyond low-single-digit growth, and PRGP savings to lift operating margin. If sales slow while costs keep rising, the turnaround could stall.